Thermo Fisher Scientific Preventative Maintenance Agreement for Incubators
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), Clinical Center, intends to award a sole-source, firm-fixed-price contract to Thermo Fisher Scientific (Asheville) LLC for a Preventative Maintenance Agreement covering Thermo Scientific HERAcell VIOS 160i CO2 and STERI-CULT INC 8 Incubators. This action ensures the continued operation and regulatory compliance of critical laboratory equipment used in manufacturing life-saving cell-based therapies.
Scope of Work
This agreement covers preventative maintenance, calibration, and manufacturer-approved servicing for 48 Thermo Scientific HERAcell VIOS 160i CO2 Incubators and 2 Thermo Scientific STERI-CULT INC 8 Incubators. Services must ensure compliance with cGMP and FDA regulations (21 CFR Parts 210, 211, 600, and 1271), including proprietary software and firmware updates.
Contract & Timeline
- Type: Firm-Fixed-Price, Sole-Source Intent
- Authority: FAR 13.106-1(b)(1) – Soliciting from a Single Source (Simplified Acquisition Procedures)
- Set-Aside: None (Sole Source)
- Response Due: March 20, 2026, 8:30 AM EST
- Published: March 10, 2026
Justification & Capability Statement Requirements
Thermo Fisher Scientific is the Original Equipment Manufacturer (OEM) and the only vendor capable of providing manufacturer-authorized services, proprietary updates, and certified maintenance required for system validation and regulatory compliance. Disruption to these systems would delay production of critical cell therapies for patients.
While this is not a request for quotations, interested parties may submit a capability statement demonstrating the ability to provide equivalent services. Statements must clearly show:
- Manufacturer-authorized maintenance for specified incubators.
- OEM-certified technicians trained on HERAcell VIOS 160i and STERI-CULT INC 8 systems.
- Access to proprietary diagnostic tools, firmware, and software updates.
- Preventative maintenance and calibration compliant with cGMP.
- Documentation for FDA regulatory compliance and validated system status.
Additional Notes
This notice is for informational purposes only and does not constitute a request for quotations. A solicitation will not be issued. The Government will evaluate capability statements, but the determination not to compete this requirement is at its discretion.